Department of Haematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
Shandong Blood Center, Shandong Hemophilia Treatment Center, Jinan, China.
Haemophilia. 2020 Jan;26(1):122-128. doi: 10.1111/hae.13889. Epub 2019 Nov 19.
An increased bleeding tendency has been shown in female haemophilia carriers compared to healthy females. Bleeding assessment tools (BATs) have mainly been performed in western cultures. It is unclear how they perform in populations with different healthcare, health/wellness concepts and awareness, as well as family planning practices.
To (a) describe and compare the bleeding symptoms in carriers with healthy females, particularly for bleeding after surgical abortion and intrauterine device (IUD) placement which are performed frequently for family planning in China; (b) quantify scores of International Society on Thrombosis and Haemostasis Bleeding Assessment Tool (ISTH-BAT) and Chinese-BAT (C-BAT) developed to include surgical abortion and IUD placement as separate categories in Chinese haemophilia carriers; (c) correlate bleeding scores (BS) with factor levels.
We conducted a multicentre, cross-sectional study on obligate haemophilia carriers and healthy controls using ISTH-BAT and C-BAT.
We enrolled 125 haemophilia carriers and 106 controls. Carriers, compared to controls, had significantly higher median BS (3 vs 1 by both ISTH-BAT and C-BAT) and lower factor level (63.5 vs 101.8 IU/dL). Bleeding after surgical abortion and IUD placement was significantly associated with carrier status. Bleeding scores from neither ISTH-BAT nor C-BAT showed significant correlation with factor levels.
Haemophilia carriers in China experienced abnormal bleeding. Unique to the Chinese carriers is significant bleeding after surgical abortion (3rd highest incidence of bleeding symptom) and IUD placement (4th highest). However, both ISTH-BAT and C-BAT exhibited no correlation between BS and factor levels in this population and neither could identify carriers with low factor level (of <50 IU/dL).
与健康女性相比,女性血友病携带者的出血倾向增加。出血评估工具(BATs)主要在西方文化中进行。尚不清楚它们在具有不同医疗保健、健康/保健观念以及计划生育实践的人群中表现如何。
(a)描述和比较携带者与健康女性的出血症状,特别是在中国经常用于计划生育的人工流产后和宫内节育器(IUD)放置后的出血症状;(b)量化国际血栓和止血学会出血评估工具(ISTH-BAT)和中国出血评估工具(C-BAT)的评分,该工具开发了包括人工流产和 IUD 放置作为中国血友病携带者的单独类别;(c)将出血评分(BS)与因子水平相关联。
我们使用 ISTH-BAT 和 C-BAT 对义务血友病携带者和健康对照进行了多中心、横断面研究。
我们招募了 125 名血友病携带者和 106 名对照。与对照组相比,携带者的中位 BS 明显更高(ISTH-BAT 和 C-BAT 分别为 3 和 1),因子水平明显更低(63.5 和 101.8 IU/dL)。人工流产后和 IUD 放置后的出血与携带者状态显著相关。ISTH-BAT 和 C-BAT 的出血评分均与因子水平无显著相关性。
中国的血友病携带者经历了异常出血。中国携带者的独特之处在于人工流产后(出血症状发生率第三高)和 IUD 放置后(出血症状发生率第四高)明显出血。然而,ISTH-BAT 和 C-BAT 在该人群中均未显示 BS 与因子水平之间存在相关性,也未能识别因子水平较低(<50 IU/dL)的携带者。